Abstract
Cancer nanotheranostics has emerged as one of the most promising fields of medicine wherein nano-sized molecules/agents are used for combined diagnosis and treatment of cancer. Despite promises of novel cancer therapeutic approaches, several crucial challenges have remained to be overcome for successful clinical translation of such agents. Hence, the present study has been aimed to investigate the therapeutic efficacy of bimetallic gadolinium super-paramagnetic iron oxide nanoformulation of ascorbic acid in synergism with hyperthermia on ascorbic acid-resistant breast cancer cells. This particular strategy provides real-time MRI-based non-invasive imaging of drug loading in resistant cancer cells along with highly enhanced therapeutic efficacy. This unique redox nanoprobe is capable of reversing drug-resistance mechanism in cancer cells and offers better therapeutic possibilities in targeted and effective destruction of drug-resistant cancer cells.
Similar content being viewed by others
References
Athar T, Vishwakarma SK, Bardia A, Khan AA (2016) Super paramagnetic iron oxide and gadolinium (FeGdO3) nanopowder synthesized by hydrolytic approach passes high level of biocompatibility and MRI-based dual contrast property for competent molecular imaging and therapeutic interventions. Biomed Phys Eng Express 2:025010
Chen H, Zhang W, Zhu G, Xie J, Chen X (2017) Rethinking cancer nanotheranostics. Nat Rev Mater 2:17024
Conde J, Tian F, De la Fuente JM, Baptista PV (2016) Editorial: cancer nanotheranostics: what have we learned so far? Front Chem 3:71
Dissanayake NM, Current KM, Obare SO (2015) Mutagenic effects of iron oxide nanoparticles on biological cells. Int J Mol Sci 16:23482–23516
Fei L, Perrett S (2009) Effect of nanoparticles on protein folding and fibrillogenesis. Int J Mol Sci 10:646–655
Gajbhiye KR, Gajbhiye V, Siddiqui IA, Pilla S, Soni V (2017) Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: an in vitro-in vivo study. Sci Rep 7:11086
Hervault A, Thanh NTK (2014) Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale 6:11553–11573
Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43:33–56
Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers (Basel) 6:1769–1792
Itoh Y, Yamada Y, Kazaoka Y, Ishiguchi T, Honda N (2010) Combination of chemotherapy and mild hyperthermia enhances the anti-tumor effects of cisplatin and adriamycin in human bladder cancer T24 cells in vitro. Exp Ther Med 1:319–323
Jaramillo AC, Saig FA, Cloos J, Jansen G, Peters GJ (2018) How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance? Cancer Drug Resist 1:6–29
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Krolikowska A, Kudelski A, Michota A, Bukowska J (2003) SERS studies on the structure of thioglycolic acid monolayers on silver and gold. Surf Sci 532:227–232
Kuiper C, Vissers MCM (2014) Ascorbate as a co-factor for Fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol 4:359
Kumar V, Yadav SK (2009) Plant-mediated synthesis of silver and gold nanoparticles and their applications. J Chem Technol Biotechnol 84:151–157
Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, Doroshow JH (2012) Advances in using PARP inhibitors to treat cancer. BMC Med 10:25
Lepock JR (2003) Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperth 19:252–266
Lin G, Mi P, Chu C, Zhang J, Liu G (2016) Inorganic nanocarriers overcoming multidrug resistance for cancer theranostics. Adv Sci 3:1600134
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 25:402–408
Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207
Mandl J, Szarka A, Bánhegyi G (2009) Vitamin C: update on physiology and pharmacology. Br J Pharmacol 157:1097–1110
Mehtala JG, Torrengrosa-Allen S, Elzey AD, Jeon M, Kim C, Wei A (2014) Synergetic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors. Nanomedicine 9:1939–1955
Molavian HR, Goldman A, Phipps CJ, Kohandel M, Wouters BG, Sengupta S, Sivaloganathan S (2016) Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects. Sci Rep 6:27439
Moribe K, Limwikrant W, Higashi K, Yamamoto K (2011) Drug nanoparticle formulation using ascorbic acid derivatives. J Drug Deliv 138929:1–9
Peters GJ (2018) Cancer drug resistance: a new perspective. Cancer Drug Resist 1:1–5
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Pollard HB, Levine MA, Eidelman O, Pollard M (2010) Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer. In Vivo 24:249–256
Quinto CA, Mohindra P, Tong S, Bao G (2015) Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment. Nanoscale 7:12728–12736
Sadhukha T, Niu L, Wiedmann TS, Panyam J (2013) Effective elimination of cancer stem cells by magnetic hyperthermia. Mol Pharm 10:1432–1441
Sampath D, Cortes J, Estrov Z, Du M, Shi Z, Andreeff M, Gandhi V, Plunkett W (2006) Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood 107:2517–2524
Sawyers C (2004) Targeted cancer therapy. Nature 432:294–297
Soares PIP, Ferreira IMM, Igreja RAGBN., Novo CMM, Borges JPMR. (2012) Application of hyperthermia for cancer treatment: recent patents review. Recent Pat Anticancer Drug Discov 7:64–73
Vishwakarma SK, Bardia A, Paspala SAB, Khan AA (2015) Magnetic nanoparticle tagged stem cell transplantation in spinal cord injury: a promising approach for targeted homing of cells at the lesion site. Neurol India 63:460–461
Vishwakarma SK, Sharmila P, Bardia A, Chandrakala L, Raju N, Sravani G, Sastry BVS, Habeeb MA, Khan AA, Dhayal M (2017) Use of biocompatible sorafenib-gold nanoconjugates for reversal of drug resistance in human hepatoblastoma. Cells Sci Rep 7:8539
Vishwakarma SK, Bardia A, Lakkireddy C, Paspala SAB, Habeeb MA, Khan AA (2018) Real-time cellular and molecular dynamics of bi-metallic self-therapeutic nanoparticle in cancer cells. Appl Nanosci 8:115–124
Wen L, Yang S, Zhong J, Zhou Q, Xing D (2017) Thermoacoustic imaging and therapy guidance based on ultra-short pulsed microwave pumped thermoelastic effect induced with superparamagnetic iron oxide nanoparticles. Theranostics 7:1976–1989
Wo F, Xu R, Shao Y, Zhang Z, Chu M, Shi D, Liu S (2016) A multimodel system with synergetic effects of magneto-mechanical, photothermal, photodynamic and chemo therapies of cancer in grapheme-quantum dot-coated hollow magnetic nanospheres. Theranostics 6:485–500
Zahreddine H, Borden KLB (2013) Mechanisms and insights into drug resistance in cancer. Front Pharmacol 4:28
Acknowledgements
The authors thank the Department of Radiology, Princess Esra Hospital, Hyderabad, for providing facility to conduct MRI contrast imaging.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vishwakarma, S.K., Lakkireddy, C., Marjan, T. et al. Bimetallic redox nanoprobe enhances the therapeutic efficacy of hyperthermia in drug-resistant cancer cells. Appl Nanosci 8, 1493–1504 (2018). https://doi.org/10.1007/s13204-018-0814-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13204-018-0814-9